Jason Bednar
Stock Analyst at Piper Sandler
(2.42)
# 2,411
Out of 4,884 analysts
173
Total ratings
44.93%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCR NovoCure | Reiterates: Overweight | $34 | $17.71 | +91.98% | 11 | Jun 27, 2025 | |
| COO The Cooper Companies | Reiterates: Overweight | $115 → $105 | $73.30 | +43.25% | 13 | May 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $110 | $93.58 | +17.55% | 12 | May 23, 2025 | |
| SOLV Solventum | Upgrades: Overweight | $78 → $87 | $78.50 | +10.83% | 6 | May 19, 2025 | |
| KRMD KORU Medical Systems | Maintains: Neutral | $4.5 → $3.5 | $3.62 | -3.31% | 7 | May 8, 2025 | |
| MASI Masimo | Reiterates: Overweight | $215 → $200 | $167.57 | +19.35% | 15 | May 7, 2025 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $260 → $185 | $176.16 | +5.02% | 9 | May 2, 2025 | |
| LUNG Pulmonx | Reiterates: Overweight | $10 → $9 | $2.78 | +223.74% | 11 | May 1, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $235 → $250 | $196.82 | +27.02% | 30 | May 1, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $20 → $16 | $16.67 | -4.02% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $74.67 | +3.12% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $17 | $20.39 | -16.63% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $13 | $11.75 | +10.69% | 2 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $1.59 | +183.02% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $237.55 | +11.56% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $2.19 | +173.97% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $3.17 | +120.82% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3.5 → $1 | $0.18 | +458.66% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $544.47 | -31.68% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $76.07 | +24.88% | 1 | Apr 19, 2023 |
NovoCure
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $17.71
Upside: +91.98%
The Cooper Companies
May 30, 2025
Reiterates: Overweight
Price Target: $115 → $105
Current: $73.30
Upside: +43.25%
Merit Medical Systems
May 23, 2025
Maintains: Overweight
Price Target: $106 → $110
Current: $93.58
Upside: +17.55%
Solventum
May 19, 2025
Upgrades: Overweight
Price Target: $78 → $87
Current: $78.50
Upside: +10.83%
KORU Medical Systems
May 8, 2025
Maintains: Neutral
Price Target: $4.5 → $3.5
Current: $3.62
Upside: -3.31%
Masimo
May 7, 2025
Reiterates: Overweight
Price Target: $215 → $200
Current: $167.57
Upside: +19.35%
Becton, Dickinson and Company
May 2, 2025
Downgrades: Neutral
Price Target: $260 → $185
Current: $176.16
Upside: +5.02%
Pulmonx
May 1, 2025
Reiterates: Overweight
Price Target: $10 → $9
Current: $2.78
Upside: +223.74%
Align Technology
May 1, 2025
Reiterates: Overweight
Price Target: $235 → $250
Current: $196.82
Upside: +27.02%
DENTSPLY SIRONA
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $16.67
Upside: -4.02%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $74.67
Upside: +3.12%
Apr 30, 2025
Maintains: Neutral
Price Target: $18 → $17
Current: $20.39
Upside: -16.63%
Apr 23, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $11.75
Upside: +10.69%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $1.59
Upside: +183.02%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $237.55
Upside: +11.56%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $2.19
Upside: +173.97%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $3.17
Upside: +120.82%
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.18
Upside: +458.66%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $544.47
Upside: -31.68%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $76.07
Upside: +24.88%